Abstract
Tumor necrosis factor (TNF) is a cytokine with well known anticancer properties and is being utilized as anticancer agent for the treatment of patients with locally advanced solid tumors. However, TNF role in cancer biology is debated. In fact, in spite of the wealth of evidence supporting its antitumor activity, the cascade of molecular events underlying TNF-mediated tumor regression observed in vivo is still incompletely elucidated. Furthermore, some preclinical findings suggest that TNF may even promote cancer development and progression. With this work we intend to summarize the molecular biology of TNF (with particular regard to its tumor-related activities) and review the experimental and clinical evidence currently available describing the complex and sometime apparently conflicting relationship between this cytokine, cancer biology and antitumor therapy. We also propose a model to explain the dual effect of TNF based on the exposure time and cytokine levels reached within the tumor microenvironment. Finally, we overview recent research findings that might lead to new ways for exploiting the anticancer potential of TNF in the clinical setting.
Keywords: Tumor necrosis factor, TNF, cancer, biology, therapy, chemotherapeutic agents, cancer biotherapy, Coley's toxin, TNF PATHWAY, TNF-converting enzyme, TACE, (DISC), transcription factors, (SODD), programmedcell-death, apoptosis, FLICE, ceramide, ANTICANCER, cathepsin-B, murine fibrosarcoma, haemorrhagic necrosis, thromosis, pro-coagulant tissue factor, NOS, antineoplastic agents, malignant cells, protein kinase-C, carcinogenesis, angiogenesis, Cancer anorexia-cachexia syndrome, single nucleotide polymorphisms, isolated limb perfusion, isolated hepatic perfusion, ANTI-TNF THERAPY, TNF-antagonists, TNF Muteins, NFkB Pathway, NFkB, proapoptotic factors, NSAID, PKB/Akt
Current Medicinal Chemistry
Title: The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
Volume: 17 Issue: 29
Author(s): L. Bertazza and S. Mocellin
Affiliation:
Keywords: Tumor necrosis factor, TNF, cancer, biology, therapy, chemotherapeutic agents, cancer biotherapy, Coley's toxin, TNF PATHWAY, TNF-converting enzyme, TACE, (DISC), transcription factors, (SODD), programmedcell-death, apoptosis, FLICE, ceramide, ANTICANCER, cathepsin-B, murine fibrosarcoma, haemorrhagic necrosis, thromosis, pro-coagulant tissue factor, NOS, antineoplastic agents, malignant cells, protein kinase-C, carcinogenesis, angiogenesis, Cancer anorexia-cachexia syndrome, single nucleotide polymorphisms, isolated limb perfusion, isolated hepatic perfusion, ANTI-TNF THERAPY, TNF-antagonists, TNF Muteins, NFkB Pathway, NFkB, proapoptotic factors, NSAID, PKB/Akt
Abstract: Tumor necrosis factor (TNF) is a cytokine with well known anticancer properties and is being utilized as anticancer agent for the treatment of patients with locally advanced solid tumors. However, TNF role in cancer biology is debated. In fact, in spite of the wealth of evidence supporting its antitumor activity, the cascade of molecular events underlying TNF-mediated tumor regression observed in vivo is still incompletely elucidated. Furthermore, some preclinical findings suggest that TNF may even promote cancer development and progression. With this work we intend to summarize the molecular biology of TNF (with particular regard to its tumor-related activities) and review the experimental and clinical evidence currently available describing the complex and sometime apparently conflicting relationship between this cytokine, cancer biology and antitumor therapy. We also propose a model to explain the dual effect of TNF based on the exposure time and cytokine levels reached within the tumor microenvironment. Finally, we overview recent research findings that might lead to new ways for exploiting the anticancer potential of TNF in the clinical setting.
Export Options
About this article
Cite this article as:
Bertazza L. and Mocellin S., The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology, Current Medicinal Chemistry 2010; 17 (29) . https://dx.doi.org/10.2174/092986710793176339
DOI https://dx.doi.org/10.2174/092986710793176339 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews Prospects for Discovering the Secondary Metabolites of <i>Cordyceps</i> Sensu Lato by the Integrated Strategy
Medicinal Chemistry A Catalytically Inactive Lys49 PLA2 Isoform from Bothrops jararacussu venom that Stimulates Insulin Secretion in Pancreatic Beta Cells
Protein & Peptide Letters The Role of Natural Killer T Cells in Acute Kidney Injury: Angel or Evil?
Current Protein & Peptide Science Synthetic Cannabinoids as Drugs of Abuse
Current Drug Abuse Reviews Synthesis of Novel Test Compounds for Antiviral Chemotherapy of Severe Acute Respiratory Syndrome (SARS)
Current Medicinal Chemistry Design and Synthesis of Dopaminergic Agonists
Current Medicinal Chemistry Implication for Thiazolidinediones (TZDs) as Novel Potential Anti- Inflammatory Drugs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Herbal Medicine of the 21st Century: A Focus on the Chemistry, Pharmacokinetics and Toxicity of Five Widely Advocated Phytotherapies
Current Topics in Medicinal Chemistry Recreational Drug Misuse and Stroke
Current Drug Abuse Reviews Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
CNS & Neurological Disorders - Drug Targets Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology Prevention of Non-immune Mediated Transfusion-related Acute Lung Injury; from Blood Bank to Patient
Current Pharmaceutical Design Neuroprotection and Regeneration Strategies for Spinal Cord Repair
Current Pharmaceutical Design Vasopressin in Liver Disease – Should We Turn On or Off?
Current Clinical Pharmacology Beneficial Extracardiac Effects of Cardiovascular Medications
Current Cardiology Reviews Pharmacological Effects of Biotin in Animals
Mini-Reviews in Medicinal Chemistry Pharmacogenetic Studies of Psychotropic Drug-Induced Adverse Effects
Current Pharmacogenomics